1. Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis. (3rd October 2022) Authors: Jirak, P; Van Almsick, V; Dimitroulis, D; Mirna, M; Seelmaier, C; Shomanova, Z; Semo, D; Dankl, D; Mahringer, M; Lichtenauer, M; Hoppe, U; Reinecke, H; Pistulli, R; Larbig, R; Motloch, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia. (14th October 2021) Authors: Jirak, P; Shomanova, Z; Larbig, R; Dankl, D; Frank, N; Seelmaier, C; Butkiene, D; Lichtenauer, M; Strohmer, B; Sackarnd, J; Hoppe, U; Sindermann, J; Reinecke, H; Pistulli, R; Motloch, L Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients. (3rd October 2022) Authors: Van Almsick, V; Jirak, P; Dimitroulis, D; Mirna, M; Seelmaier, C; Shomanova, Z; Semo, D; Dankl, D; Mahringer, M; Lichtenauer, M; Hoppe, U; Reinecke, H; Larbig, R; Motloch, L; Pistulli, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗